Status: Planned First registered on: 02/04/2020
Last updated on: 02/04/2020
1. Study identification
EU PAS Register NumberEUPAS34469
Official titleDescription of the cutaneous manifestations of Covid-19
Study title acronymCOVID-PIEL
Study typeObservational study
Brief description of the studyObservational transversal descriptive study with the main objective to describe the clinical characteristics and symptoms of the cutaneous manifestations associated with COVID-19. The secondary objectives are: o Identify the chronology of the cutaneous manifestations associated with COVID-19. o Evaluate the eventual relationship of skin manifestations with current COVID-19 treatments. o Evaluate the relationship of cutaneous manifestations associated with analytical parameters.
Was this study requested by a regulator?No
Is the study required by a Risk Management Plan (RMP)? Not applicable
Regulatory procedure number (RMP Category 1 and 2 studies only)
Other study registration identification numbers and URLs as applicableACG-CLO2020-01 Agencia Española del Medicamento
2. Research centres and Investigator details
Coordinating study entity
Centre nameHospital de Móstoles
Centre locationMóstoles. Madrid. Spain
Details of (Primary) lead investigator
Title Ms
Last name Galvan Casas
First name Cristina
Is this study being carried out with the collaboration of a research network?
No
Other centres where this study is being conducted
Multiple centres

In total how many centres are involved in this Study?3

AEMPS
Hospital Plato, Barcelona
Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria
Countries in which this study is being conducted
National study

Spain
3. Study timelines: initial administrative steps, progress reports and final report
PlannedActual
Date when funding contract was signed31/03/2020
Start date of data collection06/04/2020
Start date of data analysis21/04/2020
Date of interim report, if expected21/04/2020
Date of final study report30/04/2020
4. Sources of funding
Please provide estimates of the percentage of funding by source for this study
Names(s)Approximate % funding
Pharmaceutical companies
Charities
Government body
Research councils
EU funding scheme
OtherPrincipal Investigators100
5. Contact details for enquiries
Scientific Enquiries
Title Ms
Last name Galvan Casas
First name Cristina
Address line 1PINTOR ZULOAGA, 15
Address line 2 
Address line 3 
CityVILLANUEVA DE LA CAÑADA 
Postcode28691 
CountrySpain
Phone number (incl. country code)0034649578784 
Alternative phone number 
Fax number (incl. country code) 
Email address covidpiel@gmail.com
Public Enquiries
Title Ms 
Last name Galvan Casas 
First name Cristina 
Address line 1PINTOR ZULOAGA, 15 
Address line 2 
Address line 3 
CityVILLANUEVA DE LA CAÑADA 
Postcode28691 
CountrySpain 
Phone number (incl. country code)0034649578784 
Alternative phone number 
Fax number (incl. country code) 
Email address covidpiel@gmail.com 
Top